Analystreport

Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $456.00 price target on the sto...

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com